Bottom line
How much do FBIOX and FBDIX overlap?
35% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 26.1% of FBIOX's assets and 29.9% of FBDIX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBIOX and FBDIX have in common
| Holding | % of FBIOX | % of FBDIX | Overlap |
|---|---|---|---|
| Amgen Inc | 6.53% | 4.39% | 4.39% |
| Gilead Sciences Inc | 4.82% | 3.86% | 3.86% |
| Praxis Precision Medicines Inc. | 2.47% | 1.91% | 1.91% |
| Insmed Inc | 2.25% | 1.99% | 1.99% |
| Argenx Se | 2.25% | 3.62% | 2.25% |
| Ascendis Pharma A/s | 2.04% | 2.56% | 2.04% |
| Revolution Medicines Inc | 2.02% | 3.01% | 2.02% |
| Jazz Pharmaceuticals Plc | 1.84% | 5.66% | 1.84% |
| Tango Therapeutics Inc | 0.98% | 1.23% | 0.98% |
| Bridgebio Pharma Inc | 0.89% | 1.67% | 0.89% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBIOX
- Krystal Biotech Inc — 10.58%
- Abbvie Inc — 9.22%
- Fidelity Revere Street Trust — 3.35%
- Alnylam Pharmaceuticals Inc — 2.93%
- Ucb Sa — 2.00%
- Scholar Rock Holding Corp — 1.55%
- Natera Inc — 1.41%
- Moderna Inc — 1.28%
- Axsome Therapeutics Inc — 1.28%
- Biogen Inc — 1.26%
- Protagonist Therapeutics Inc — 1.15%
- Roivant Sciences Ltd — 1.13%
- Cogent Biosciences Inc — 1.07%
- Celcuity Inc — 0.95%
- Madrigal Pharmaceuticals Inc — 0.93%
Only in FBDIX
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Guardant Health, Inc. — 2.76%
- Dianthus Therapeutics, Inc. — 2.32%
- Mirum Pharmaceuticals, Inc. — 1.98%
- Spyre Therapeutics, Inc. — 1.87%
- Oruka Therapeutics, Inc. — 1.86%
- Neurocrine Biosciences, Inc. — 1.82%
- PTC Therapeutics, Inc. — 1.65%
- AstraZeneca plc — 1.51%
- Franklin Institutional U.S. Government Money Market Fund — 1.45%
- Amylyx Pharmaceuticals, Inc. — 1.32%
- Eli Lilly & Co. — 1.31%
- Cytokinetics, Inc. — 1.24%
Asset mix
| Asset type | FBIOX | FBDIX |
|---|---|---|
| Stocks | 99.0% | 97.0% |
| Cash & short-term funds | 3.5% | 4.6% |
| Preferred stock | 0.9% | 1.0% |
| Other | — | 0.6% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Country mix
| Country | FBIOX | FBDIX |
|---|---|---|
| US | 88.5% | 82.0% |
| IE | 2.0% | 6.7% |
| NL | 2.9% | 4.5% |
| DK | 2.6% | 2.6% |
| BE | 2.0% | — |
| FR | 0.8% | 1.7% |
| GB | 0.8% | 1.5% |
| CA | 0.4% | 1.3% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do FBIOX and FBDIX overlap?
What stocks do FBIOX and FBDIX have in common?
Should I own both FBIOX and FBDIX?
Which holds more stocks, FBIOX or FBDIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.